Matt Delaney

Matt Delaney serves as the Chief Business Development Officer at Benuvia Operations, LLC, since June 2024. Prior to this role, Delaney held various leadership positions in business development within the life sciences sector, including Vice President roles at Exela Pharma Sciences LLC and Cytovance Biologics. Delaney's extensive experience encompasses significant contributions to Contract Development and Manufacturing Organizations (CDMOs) and Clinical Research Organizations (CROs), working at notable companies such as Lake Pharma (now Curia), Nitto Denko Avecia Inc., Pharm-Olam (now Allucent), and Datatrak International. Delaney's educational background includes an MBA from San Diego State University, with additional certifications in International Business and Finance from Western International University.